Table 3.
Variables | Group A | Group B | Group C | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
rs7903146 | rs12255372 | rs7903146 | rs12255372 | rs7903146 | rs12255372 | |||||||
(CC) | (CT/TT) | (GG) | (GT/TT) | (CC) | (CT/TT) | (GG) | (GT/TT) | (CC) | (CT/TT) | (GG) | (GT/TT) | |
Age (years) | 38.1±1.7 | 35±1.4 | 38.9±1.2 | 32.3±1.6 | 53.13±1.9 | 45±2.7 | 51.2±1.4 | 39.6±4.2 | 59.4±2.6 | 55.79±2.3 | 58.5±2.5 | 56.62±2.5 |
Age onset (years) | 34.8±1.1 | 32.3±1.1 | 35.2±0.9 | 29.48±1.4 | 35.38±2.1 | 29.8±2.3 | 34.4±1.6 | 26.7±3 | 42.8±2.59 | 40.18±2.46 | 43.1±2.4 | 42±3 |
BMI (kg/m2) | 28.6±1.7 | 29.5±1.5 | 27.5±1.1 | 31.1±2.1 | 30.08±1.1 | 26.8±1.4 | 28.2±0.9 | 23.7±2.4 | 25.31±1.2 | 25.25±0.7 | 25.96±1.0 | 24.5±0.9 |
HbA1c (%) | 9±0.8 | 8.16±1.1 | 9±0.7 | 7.3±1.2 | 10.65±0.6 | 10.2±0.5 | 10.26±0.4 | 9.1±1 | 8.08±0.4 | 7.96±0.5 | 8.51±0.5 | 9.22±0.5 |
TGL (mg/dl) | 193±47.7 | 275.2±44.6 | 257.3±46.5 | 225.8±48.6 | 281.5±93.1 | 237±54.7 | 293.6±62 | 215.1±46.2 | 161.0±27.2 | 233.3±48 | 202.2±45.5 | 200.6±32.7 |
T.CHO (mg/dl) | 213.8±21.5 | 200.2±15 | 210.9±15.8 | 193.4±19.0 | 177.4±24.7 | 173.5±15.2 | 168.9±15.8 | 150.9±21 | 254.2±11.3 | 288.8±30.9* | 268.9±26.3 | 268.7±23.7 |